Lite Strategy (LITS) Operating Leases (2020 - 2024)
Lite Strategy (LITS) posted Operating Leases of $10.6 million for Q1 2024, down 3.61% on a QoQ basis from $11.0 million in Q4 2023, and down 9.02% year-over-year from $11.7 million in Q2 2023.
Analysis
Lite Strategy (LITS) Operating Leases (2020 - 2024) Analysis & Trends
Lite Strategy has reported Operating Leases for 5 years, with the latest figure at $10.6 million in Q1 2024.
- On a quarterly basis, Operating Leases fell 9.02% year-over-year to $10.6 million in Q1 2024; TTM through Mar 2024 was $10.6 million, a 9.02% decrease from a year earlier, with the FY2023 full-year figure at $11.3 million, up 28.83% from the prior year.
- Operating Leases was $10.6 million for Q1 2024 at Lite Strategy, down from $11.0 million in the prior quarter.
- The five-year high for Operating Leases was $12.4 million in Q3 2022, with the low at $6.9 million in Q4 2021.
- Average Operating Leases over 5 years is $9.7 million, with a median of $9.2 million recorded in 2022.
- The sharpest annual moves came in 2021 and 2022: Operating Leases retreated 21.34% in 2021, then surged 75.45% in 2022.
- Over 5 years, Operating Leases stood at $8.7 million in 2020, then fell by 21.34% to $6.9 million in 2021, then surged by 75.45% to $12.0 million in 2022, then declined by 8.44% to $11.0 million in 2023, then slipped by 3.61% to $10.6 million in 2024.
- The last three Operating Leases figures came in at $10.6 million (Q1 2024), $11.0 million (Q4 2023), and $11.3 million (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 10.62 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 11.33 Mn |
| Jun 30, 2023 | 11.30 Mn |
| Mar 31, 2023 | 11.67 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 12.38 Mn |
| Jun 30, 2022 | 8.77 Mn |
| Mar 31, 2022 | 9.21 Mn |
| Dec 31, 2021 | 6.86 Mn |
| Sep 30, 2021 | 7.12 Mn |
| Jun 30, 2021 | 7.37 Mn |
| Mar 31, 2021 | 8.51 Mn |
| Dec 31, 2020 | 8.72 Mn |
| Sep 30, 2020 | 8.67 Mn |